Genovis continues to expand in Asia and has signed a distribution agreement with Shanghai Titan Scientific Ltd.  A growing number of companies in China are focusing on biopharmaceuticals, at the same time that global pharmaceutical companies are locating their process development and production in the area. Consequently there is a strong need for Genovis’ products […]

SAN DIEGO, CA–Invivoscribe® Technologies Inc., a global company with decades of experience providing clonality and biomarker test solutions for the fields of oncology and personalized molecular medicine®, announces the release of the Research Use Only (RUO) version of its LymphoTrack® TRB Assay for the Illumina MiSeq® platform. Included with the assay is specialized bioinformatics software that allows researchers and […]

Pleasanton, CA – Unchained Labs, the life sciences company that’s all about getting biologics researchers the right tool for the job, announced the opening of its new office in Japan and new London location today.  The new Tokyo office, right in the heart of the city, is Unchained Labs’ 6th office worldwide. Unchained Labs is headquartered […]

Innovative animal-free cell culture improves consistency, safety and efficiency  Berlin, Germany – InVitria, a division of Ventria Bioscience, has announced the launch of a new media formulation service at the international BIO-Europe conference in Berlin, Germany. Leveraging Ventria’s proprietary ExpressTec technology, InVitria has developed and commercialized eight recombinant proteins and cell culture media supplements made in a completely animal-free system. Animal-component […]

SAN DIEGO — Organovo Holdings, Inc.(NASDAQ:ONVO) (“Organovo”) and Viscient Biosciences (“Viscient”) today announced a collaboration to develop a custom research platform for studying liver disease.  The partnership is expected to expand upon Organovo’s current service portfolio for compound screening in disease models, which aids the drug discovery work of the Company’s customers.  Viscient is targeting early […]

Walkersville, MD (USA) / Basel (CH) – Today Lonza Walkersville announced its new offering of Silensomes™ Human Liver Microsomes (HLM) products – pooled human liver microsomes for in vitro cytochrome P450 (CYP) phenotyping. CYP phenotyping is a regulatory requirement for new drug candidates to understand their metabolism and to predict drug-drug interactions. Lonza Walkersville’s new Silensomes™ HLM products provide […]

Collaboration aimed at developing novel “Nephron-on-a-Chip” device to test drug candidates in human kidney: NEPLEX (“NEPHRON-ON-A-CHIP WITH CELLULAR AND EXTRACELLULAR MATRIX COMPLEXITY”) Major step forward to the next generation kidney platform Hamburg, Germany: Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) today announced a strategic collaboration on microfluidics technology including induced pluripotent stem cell […]

As of October 2017 Micronit, Axxicon and Helvoet are collaborating in offering a market leading  development and manufacturing package to support the growing global demand for high volume polymer microfluidic products.  The strong market growth is driven by the new fast diagnostic systems being developed and entering the health care market. At the same time […]

Applied StemCell, Inc., a global provider of gene editing and stem cell-based services, as well as a leader in molecular and cellular reference standard products for clinical diagnostics markets, is proud to receive certifications for two International Organization for Standardization (ISO) Quality Management Systems (QMS) on October 20, 2017, the ISO 9001:2015 and 13485:2016. The […]

SAN DIEGO — Organovo Holdings, Inc.(NASDAQ:ONVO) (“Organovo”) and Viscient Biosciences (“Viscient”) today announced a collaboration to develop a custom research platform for studying liver disease.  The partnership is expected to expand upon Organovo’s current service portfolio for compound screening in disease models, which aids the drug discovery work of the Company’s customers.  Viscient is targeting early discovery […]